{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T02:44:06Z","timestamp":1789526646339,"version":"build-2803163510"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,17]],"date-time":"2025-07-17T00:00:00Z","timestamp":1752710400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003669","name":"Korea Centers for Disease Control and Prevention","doi-asserted-by":"publisher","award":["2020-ER6106-00"],"award-info":[{"award-number":["2020-ER6106-00"]}],"id":[{"id":"10.13039\/501100003669","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003669","name":"Korea Centers for Disease Control and Prevention","doi-asserted-by":"publisher","award":["RS-2023-00220207"],"award-info":[{"award-number":["RS-2023-00220207"]}],"id":[{"id":"10.13039\/501100003669","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["RS-2024-00441316"],"award-info":[{"award-number":["RS-2024-00441316"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100030387","name":"Maryland Society of Surveyors","doi-asserted-by":"publisher","award":["RS-2024-00512892"],"award-info":[{"award-number":["RS-2024-00512892"]}],"id":[{"id":"10.13039\/100030387","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003625","name":"Ministry of Health and Welfare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003625","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014188","name":"Korea Ministry of Science and ICT","doi-asserted-by":"publisher","award":["25A0203L1"],"award-info":[{"award-number":["25A0203L1"]}],"id":[{"id":"10.13039\/501100014188","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Advanced Research"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.jare.2025.07.030","type":"journal-article","created":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T23:22:51Z","timestamp":1753226571000},"page":"381-396","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["A machine learning platform for genotype-specific cardiotoxicity risk prediction using patient-derived iPSC-CMs"],"prefix":"10.1016","volume":"82","author":[{"given":"Yun-Gwi","family":"Park","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na Kyeong","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youngsun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Adnan","family":"Pramudito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeo-Jin","family":"Son","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyeyeon","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali Ikhsanul","family":"Qauli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seong Woo","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiwon","family":"Ban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong-Il","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soon-Jung","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8009-9546","authenticated-orcid":false,"given":"Hun-Jun","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ki Moo","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soo Kyung","family":"Koo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung-Hyun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1858-0261","authenticated-orcid":false,"given":"Sung-Hwan","family":"Moon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jare.2025.07.030_b0005","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1308217","article-title":"iPSC-cardiomyocytes in the preclinical prediction of candidate pharmaceutical toxicity","volume":"15","author":"Lee","year":"2024","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jare.2025.07.030_b0010","doi-asserted-by":"crossref","first-page":"668","DOI":"10.3389\/fphys.2017.00668","article-title":"Human in silico drug trials demonstrate higher accuracy than animal models in predicting clinical pro-arrhythmic cardiotoxicity","volume":"8","author":"Passini","year":"2017","journal-title":"Front Physiol"},{"issue":"5","key":"10.1016\/j.jare.2025.07.030_b0015","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1177\/2042098612454283","article-title":"Drug-induced QT interval prolongation: mechanisms and clinical management","volume":"3","author":"Nachimuthu","year":"2012","journal-title":"Ther Adv Drug Saf"},{"issue":"1","key":"10.1016\/j.jare.2025.07.030_b0020","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S0008-6363(02)00846-5","article-title":"Relationships between preclinical cardiac electrophysiology, clinical QT interval prolongation and torsade de pointes for a broad range of drugs: evidence for a provisional safety margin in drug development","volume":"58","author":"Redfern","year":"2003","journal-title":"Cardiovasc Res"},{"issue":"2","key":"10.1016\/j.jare.2025.07.030_b0025","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1093\/toxsci\/kfy110","article-title":"Cross-site reliability of human induced pluripotent stem cell-derived cardiomyocyte based safety assays using microelectrode arrays: results from a blinded CiPA pilot study","volume":"164","author":"Millard","year":"2018","journal-title":"Toxicol Sci"},{"key":"10.1016\/j.jare.2025.07.030_b0030","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.vascn.2016.12.003","article-title":"A new paradigm for drug-induced torsadogenic risk assessment using human iPS cell-derived cardiomyocytes","volume":"84","author":"Ando","year":"2017","journal-title":"J Pharmacol Toxicol Methods"},{"issue":"8","key":"10.1016\/j.jare.2025.07.030_b0035","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1021\/acsptsci.2c00088","article-title":"Validating the arrhythmogenic potential of high-, intermediate-, and low-risk drugs in a human-induced pluripotent stem cell-derived cardiac microphysiological system","volume":"5","author":"Charwat","year":"2022","journal-title":"ACS Pharmacol Transl Sci"},{"issue":"2","key":"10.1016\/j.jare.2025.07.030_b0040","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1093\/toxsci\/kfz235","article-title":"Detection of drug-induced torsades de pointes arrhythmia mechanisms using hiPSC-CM syncytial monolayers in a high-throughput screening voltage sensitive dye assay","volume":"173","author":"da Rocha","year":"2020","journal-title":"Toxicol Sci"},{"issue":"17","key":"10.1016\/j.jare.2025.07.030_b0045","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25179186","article-title":"The current state of realistic heart models for disease modelling and cardiotoxicity","volume":"25","author":"Kistamas","year":"2024","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.jare.2025.07.030_b0050","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.stem.2022.12.002","article-title":"A deep learning platform to assess drug proarrhythmia risk","volume":"30","author":"Serrano","year":"2023","journal-title":"Cell Stem Cell"},{"issue":"2","key":"10.1016\/j.jare.2025.07.030_b0055","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.amjcard.2017.10.010","article-title":"Risk of cardiac events associated with antidepressant therapy in patients with long QT syndrome","volume":"121","author":"Wang","year":"2018","journal-title":"Am J Cardiol"},{"issue":"11","key":"10.1016\/j.jare.2025.07.030_b0060","doi-asserted-by":"crossref","DOI":"10.3390\/cells8111331","article-title":"hiPSCs derived cardiac cells for drug and toxicity screening and disease modeling: what micro- electrode-array analyses can tell us","volume":"8","author":"Kussauer","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.jare.2025.07.030_b0065","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2024.1407138","article-title":"Non-invasive assessment of proarrhythmic risks associated with isoprenaline and the dietary supplement ingredient synephrine using human induced pluripotent stem cell-derived cardiomyocytes","volume":"11","author":"Yuan","year":"2024","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.jare.2025.07.030_b0070","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.68714","article-title":"Deep learning detects cardiotoxicity in a high-content screen with induced pluripotent stem cell-derived cardiomyocytes","volume":"10","author":"Grafton","year":"2021","journal-title":"Elife"},{"issue":"3","key":"10.1016\/j.jare.2025.07.030_b0075","doi-asserted-by":"crossref","first-page":"e1531","DOI":"10.1002\/term.2578","article-title":"Recent progress of national banking project on homozygous HLA-typed induced pluripotent stem cells in South Korea","volume":"12","author":"Rim","year":"2018","journal-title":"J Tissue Eng Regen Med"},{"key":"10.1016\/j.jare.2025.07.030_b0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.scr.2022.102965","article-title":"Generation of integration-free induced pluripotent stem cell line (KSCBi017-a) from peripheral blood mononuclear cells of a healthy male individual","volume":"65","author":"Sam Im","year":"2022","journal-title":"Stem Cell Res"},{"issue":"1","key":"10.1016\/j.jare.2025.07.030_b0085","doi-asserted-by":"crossref","first-page":"e721","DOI":"10.1002\/ctm2.721","article-title":"Effect and application of cryopreserved three-dimensional microcardiac spheroids in myocardial infarction therapy","volume":"12","author":"Park","year":"2022","journal-title":"Clin Transl Med"},{"key":"10.1016\/j.jare.2025.07.030_b0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2020.104955","article-title":"Antiviral activity and safety of remdesivir against SARS-CoV-2 infection in human pluripotent stem cell-derived cardiomyocytes","volume":"184","author":"Choi","year":"2020","journal-title":"Antiviral Res"},{"issue":"1","key":"10.1016\/j.jare.2025.07.030_b0095","doi-asserted-by":"crossref","first-page":"3123","DOI":"10.1038\/s41467-019-11091-2","article-title":"Dual stem cell therapy synergistically improves cardiac function and vascular regeneration following myocardial infarction","volume":"10","author":"Park","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.jare.2025.07.030_b0100","series-title":"Machine learning in bio-signal analysis and diagnostic imaging","first-page":"159","article-title":"Chapter 7 - optimization of ANN architecture: a review on nature-inspired techniques","author":"Gupta","year":"2019"},{"issue":"2","key":"10.1016\/j.jare.2025.07.030_b0105","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1002\/cpt.1184","article-title":"Assessment of an in silico mechanistic model for proarrhythmia risk prediction under the CiPA initiative","volume":"105","author":"Li","year":"2019","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.jare.2025.07.030_b0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.scr.2021.102570","article-title":"Establishment of a human-induced pluripotent stem cell line, KSCBi014-a, from a long QT syndrome type 2 patient harboring a KCNH2 mutation","volume":"57","author":"Lee","year":"2021","journal-title":"Stem Cell Res"},{"issue":"2","key":"10.1016\/j.jare.2025.07.030_b0115","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1093\/hmg\/ddad165","article-title":"Translation reinitiation in c.453delC frameshift mutation of KCNH2 producing functional hERG K+ channels with mild dominant negative effect in the heterozygote patient-derived iPSC cardiomyocytes","volume":"33","author":"Park","year":"2024","journal-title":"Hum Mol Genet"},{"issue":"9","key":"10.1016\/j.jare.2025.07.030_b0120","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.3346\/jkms.2013.28.9.1388","article-title":"Single nucleotide deletion mutation of KCNH2 gene is responsible for LQT syndrome in a 3-generation Korean family","volume":"28","author":"Park","year":"2013","journal-title":"J Korean Med Sci"},{"key":"10.1016\/j.jare.2025.07.030_b0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.scr.2021.102521","article-title":"Establishment of a human induced pluripotent stem cell line, KSCBi015-a, from a long QT syndrome type 1 patient harboring a KCNQ1 mutation","volume":"56","author":"Lee","year":"2021","journal-title":"Stem Cell Res"},{"key":"10.1016\/j.jare.2025.07.030_b0130","doi-asserted-by":"crossref","unstructured":"Park NK, Choi SW, Park SJ, Woo J, Kim HJ, Kim WK, et al. Requirement of beta subunit for the reduced voltage-gated Na(+) current of a Brugada syndrome patient having novel double missense mutation (p.A385T\/R504T) of SCN5A. Korean J Physiol Pharmacol. 2024;28(4):313-22.","DOI":"10.4196\/kjpp.2024.28.4.313"},{"issue":"3","key":"10.1016\/j.jare.2025.07.030_b0135","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1007\/s00109-003-0522-z","article-title":"Genetic variations of KCNQ1, KCNH2, SCN5A, KCNE1, and KCNE2 in drug-induced long QT syndrome patients","volume":"82","author":"Paulussen","year":"2004","journal-title":"J Mol Med (Berl)"},{"issue":"15","key":"10.1016\/j.jare.2025.07.030_b0140","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1161\/01.CIR.0000125524.34234.13","article-title":"Compound mutations: a common cause of severe long-QT syndrome","volume":"109","author":"Westenskow","year":"2004","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/j.jare.2025.07.030_b0145","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1111\/j.1540-8159.2006.00507.x","article-title":"Brugada syndrome","volume":"29","author":"Antzelevitch","year":"2006","journal-title":"Pacing Clin Electrophysiol"},{"issue":"13","key":"10.1016\/j.jare.2025.07.030_b0150","doi-asserted-by":"crossref","first-page":"3582","DOI":"10.1016\/j.celrep.2018.08.079","article-title":"International multisite study of human-induced pluripotent stem cell-derived cardiomyocytes for drug proarrhythmic potential assessment","volume":"24","author":"Blinova","year":"2018","journal-title":"Cell Rep"},{"key":"10.1016\/j.jare.2025.07.030_b0155","unstructured":"CredibleMeds\u00ae. QTDrugs Lists: Drugs Associated with Risk of Torsades de Pointes: AZCERT, Inc.; 2025 [Available from: https:\/\/crediblemeds.org\/index.php\/druglist."},{"issue":"4","key":"10.1016\/j.jare.2025.07.030_b0160","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1002\/med.21476","article-title":"Comprehensive review of cardiovascular toxicity of drugs and related agents","volume":"38","author":"Mladenka","year":"2018","journal-title":"Med Res Rev"},{"issue":"D1","key":"10.1016\/j.jare.2025.07.030_b0165","doi-asserted-by":"crossref","first-page":"D1080","DOI":"10.1093\/nar\/gkv1192","article-title":"WITHDRAWN\u2013a resource for withdrawn and discontinued drugs","volume":"44","author":"Siramshetty","year":"2016","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"10.1016\/j.jare.2025.07.030_b0170","doi-asserted-by":"crossref","first-page":"3651","DOI":"10.1038\/s41598-019-40247-9","article-title":"Scaling and correlation properties of RR and QT intervals at the cellular level","volume":"9","author":"Kim","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.jare.2025.07.030_b0175","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s40360-016-0053-1","article-title":"Drug-drug interactions and QT prolongation as a commonly assessed cardiac effect - comprehensive overview of clinical trials","volume":"17","author":"Wisniowska","year":"2016","journal-title":"BMC Pharmacol Toxicol"},{"key":"10.1016\/j.jare.2025.07.030_b0180","article-title":"Investigation role of ondansetron on long QT interval among non-cardiac patients","volume":"71","author":"Tabrizi","year":"2021","journal-title":"Ann Med Surg (Lond)"},{"key":"10.1016\/j.jare.2025.07.030_b0185","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.schres.2023.09.032","article-title":"Prevalence and predictors of QTc prolongation in patients seen in a clozapine clinic in a real-world setting in Australia","volume":"268","author":"Sankaranarayanan","year":"2024","journal-title":"Schizophr Res"},{"issue":"4","key":"10.1016\/j.jare.2025.07.030_b0190","first-page":"121","article-title":"Clarithromycin, QTc interval prolongation and torsades de pointes: the need to study case reports","volume":"1","author":"Vieweg","year":"2013","journal-title":"Ther Adv Infect Dis"},{"key":"10.1016\/j.jare.2025.07.030_b0195","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.ijcard.2015.01.020","article-title":"Clarithromycin for stable coronary heart disease increases all-cause and cardiovascular mortality and cerebrovascular morbidity over 10years in the CLARICOR randomised, blinded clinical trial","volume":"182","author":"Winkel","year":"2015","journal-title":"Int J Cardiol"},{"issue":"221","key":"10.1016\/j.jare.2025.07.030_b0200","first-page":"285","article-title":"Cardiac arrest and electrical storm due to recurrent torsades de pointes caused by concomitant clarithromycin, cotrimoxazole and amiodarone treatment","volume":"37","author":"Bienias","year":"2014","journal-title":"Pol Merkur Lekarski"},{"issue":"49","key":"10.1016\/j.jare.2025.07.030_b0205","doi-asserted-by":"crossref","first-page":"e9071","DOI":"10.1097\/MD.0000000000009071","article-title":"QTc prolongation and torsades de pointes due to a coadministration of fluoxetine and amiodarone in a patient with implantable cardioverter-defibrillator: Case report and review of the literature","volume":"96","author":"Wei","year":"2017","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jare.2025.07.030_b0210","article-title":"Remdesivir associated sinus bradycardia in patients with COVID-19: a prospective longitudinal study","volume":"13","author":"Hajimoradi","year":"2022","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jare.2025.07.030_b0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2025.117426","article-title":"In silico cardiac safety profile of drugs and their potential to induce clinical cardiotoxicity","volume":"502","author":"Christophe","year":"2025","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/j.jare.2025.07.030_b0220","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.vascn.2016.03.009","article-title":"An evaluation of 30 clinical drugs against the comprehensive in vitro proarrhythmia assay (CiPA) proposed ion channel panel","volume":"81","author":"Crumb","year":"2016","journal-title":"J Pharmacol Toxicol Methods"},{"issue":"3","key":"10.1016\/j.jare.2025.07.030_b0225","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1152\/physrev.00017.2023","article-title":"Computational modeling of cardiac electrophysiology and arrhythmogenesis: toward clinical translation","volume":"104","author":"Trayanova","year":"2024","journal-title":"Physiol Rev"},{"issue":"16","key":"10.1016\/j.jare.2025.07.030_b0230","doi-asserted-by":"crossref","first-page":"3871","DOI":"10.1113\/JP282562","article-title":"Advances in induced pluripotent stem cell-derived cardiac myocytes: technological breakthroughs, key discoveries and new applications","volume":"602","author":"Clancy","year":"2024","journal-title":"J Physiol"},{"issue":"8","key":"10.1016\/j.jare.2025.07.030_b0235","doi-asserted-by":"crossref","first-page":"2683","DOI":"10.1007\/s12015-023-10615-0","article-title":"Arrhythmogenic cardiomyopathy: from preclinical models to genotype-phenotype correlation and pathophysiology","volume":"19","author":"Fan","year":"2023","journal-title":"Stem Cell Rev Rep"},{"issue":"1","key":"10.1016\/j.jare.2025.07.030_b0240","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s10439-020-02521-0","article-title":"Analysis of drug effects on iPSC cardiomyocytes with machine learning","volume":"49","author":"Juhola","year":"2021","journal-title":"Ann Biomed Eng"},{"key":"10.1016\/j.jare.2025.07.030_b0245","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.3389\/fphys.2017.01096","article-title":"Composite biomarkers derived from micro-electrode array measurements and computer simulations improve the classification of drug-induced channel block","volume":"8","author":"Tixier","year":"2017","journal-title":"Front Physiol"},{"issue":"8","key":"10.1016\/j.jare.2025.07.030_b0250","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1093\/europace\/eux221","article-title":"Broad antiarrhythmic effect of mexiletine in different arrhythmia models","volume":"20","author":"Frommeyer","year":"2018","journal-title":"Europace"},{"key":"10.1016\/j.jare.2025.07.030_b0255","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2022.904664","article-title":"Effects of mexiletine on a race-specific mutation in Na(v)1.5 associated with long QT syndrome","volume":"13","author":"Wu","year":"2022","journal-title":"Front Physiol"},{"issue":"7","key":"10.1016\/j.jare.2025.07.030_b0260","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.jacbts.2019.06.004","article-title":"Electrophysiological and contractile effects of disopyramide in patients with obstructive hypertrophic cardiomyopathy: a translational study","volume":"4","author":"Coppini","year":"2019","journal-title":"JACC Basic Transl Sci"},{"key":"10.1016\/j.jare.2025.07.030_b0265","doi-asserted-by":"crossref","first-page":"203","DOI":"10.3389\/fnins.2018.00203","article-title":"Clozapine-induced cardiovascular side effects and autonomic dysfunction: a systematic review","volume":"12","author":"Yuen","year":"2018","journal-title":"Front Neurosci"}],"container-title":["Journal of Advanced Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2090123225005491?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2090123225005491?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T08:59:31Z","timestamp":1778835571000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2090123225005491"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":53,"alternative-id":["S2090123225005491"],"URL":"https:\/\/doi.org\/10.1016\/j.jare.2025.07.030","relation":{},"ISSN":["2090-1232"],"issn-type":[{"value":"2090-1232","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A machine learning platform for genotype-specific cardiotoxicity risk prediction using patient-derived iPSC-CMs","name":"articletitle","label":"Article Title"},{"value":"Journal of Advanced Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jare.2025.07.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V. on behalf of Cairo University.","name":"copyright","label":"Copyright"}]}}